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Cerium oxide nanoparticles (CNPs) are novel synthetic antioxidant agents proposed for treating 
oxidative stress-related diseases. The synthesis of high-quality CNPs for biomedical applications 
remains a challenging task. A major concern for a safe use of CNPs as pharmacological agents is their 
tendency to agglomerate. Herein we present a simple direct precipitation approach, exploiting ethylene 
glycol as synthesis co-factor, to synthesize at room temperature nanocrystalline sub-10 nm CNPs, 
followed by a surface silanization approach to improve nanoparticle dispersibility in biological fluids. 
CNPs were characterized using transmission electron microscopy (TEM) observations, X-ray diffraction 
(XRD) analysis, thermogravimetric analysis (TGA), Fourier-transform infrared (FT-IR) spectroscopy, 
proton nuclear magnetic resonance (1H-NMR) spectroscopy, dynamic light scattering (DLS) and 
zeta potential measurements. CNP redox activity was studied in abiotic systems using electron spin 
resonance (ESR) measurements, and in vitro on human cell models. In-situ silanization improved CNP 
colloidal stability, in comparison with non-functionalized particles, and allowed at the same time 
improving their original biological activity, yielding thus functionalized CNPs suitable for biomedical 
applications.
Cerium oxide (CeO2) is a rare earth oxide material used in many technological applications1. These include a 
wide range of catalytic applications2, oxygen sensors3, oxygen permeation membranes4, solid oxide fuel cells5–7, 
glass-polishing8, and as an ultraviolet absorbent9–12. In the last decade cerium oxide nanoparticles (CNPs) have 
gained a significant interest in the medical field, thanks to their self regenerating antioxidant properties, repre-
senting a promising antioxidant for healing numerous untreatable oxidative-stress-related diseases, as discussed 
in several reviews13–18. CNPs may help to solve molecular antioxidant drugs limitations, such as difficulties in 
body retention, stability and selectivity19, 20, significantly improving the usefulness of antioxidant therapy.
The Ce3+/Ce4+ redox couple on the nanoparticle surface provides CNP biological activity. Their action mech-
anism is similar to that of natural metallo-enzymes that use transition metal ions, such as Fe3+, Cu2+, or Mn3+, 
to buffer reactive oxygen species (ROS) in cells and tissues. Indeed, Ce3+ ions reduce superoxide into hydrogen 
peroxide while oxidizing into Ce4+, mimicking thus superoxide dismutase (SOD) activity21, 22. Also, oxidation of 
Ce3+ to Ce4+ permits abating other deleterious free radicals, such as hydroxyl23, nitric oxide (NO)24, and perox-
ynitrite (ONOO−)25. Instead, the reduction of Ce4+ to Ce3+ induces hydrogen peroxide oxidation to molecular 
oxygen, behaving like catalase enzyme26.
Owing to their antiradical activity, different studies have shown that CNPs help reducing symptoms of many 
oxidative stress-related diseases, including neuro-degenerations27, 28, retinitis29, chronic inflammation30, diabe-
tes31, endometriosis32, and cancer33. Therefore, the demand of CNPs into the medical field is rapidly expanding. 
However, the synthesis of high quality CNPs suitable for biomedical applications is still a challenging task34, 35.
One of the major issues that still needs to be solved for a safe and efficient use of CNPs as pharmacological 
agents is their tendency to agglomerate, experienced when CNPs are suspended in aqueous solutions as well as in 
vivo and in physiological media15. The formation of precipitates is expected to decrease the active surface area of 
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CNPs, thereby reducing their biological activity36. Importantly, nanoparticle agglomeration could cause toxicity 
and deleterious side effects37, 38. If administered in vivo, nanoparticle agglomerates may accumulate in target 
organs, such as spleen and kidney39, possibly causing the failure of their functions. Moreover, it has been recently 
demonstrated that big nanoparticle agglomerates induce incomplete phagocytosis phenomena in macrophages 
depressing the inflammatory response and producing cytotoxic cytokines40. Therefore, it is becoming very impor-
tant to develop robust synthesis methods to obtain water-dispersible CNPs.
Organic solvent-assisted synthesis41 and micro-emulsion approaches42, 43 have been proposed to synthesize 
stable CNP colloidal dispersions. However, in the above-mentioned methods not totally biocompatible sur-
factants or small organic molecules (e.g. oleic acid) are commonly used to transfer CNPs to water based media, 
causing toxic effects on cells15, 41.
Low temperature direct precipitation of nanocrystalline CNPs in water7, 34 has been also proposed as a synthetic way 
to obtain biocompatible CNPs for medical applications44–46. The use of biocompatible polymers such as PEG and dex-
tran has been explored to control the reaction kinetics15, 44, 47. After the synthesis, a residual polymeric layer remains on 
the CNPs44, 48, which should be permeable to free radicals, and should not interfere with CPN redox chemistry to avoid 
the inhibition of the CNP antioxidant activity. To enhance the CNP stability and to improve selectivity in CNP-cell 
interactions, post synthesis modification strategies of the CNP ligand shell has also been explored43, 49.
In this work, we present a suitable approach to produce biocompatible and redox active CNPs for biomedical 
use. For this purpose, we optimized two direct-precipitation synthetic ways, in particular exploiting ethylene 
glycol as synthesis co-factor, for synthesizing at room temperature nanocrystalline sub-10 nm CNPs, and then 
combined with a new post-synthesis surface functionalization strategy to improve nanoparticle dispersibility in 
biological fluids. CNP agglomeration in water-based media, redox activity, bio-compatibility and antioxidant 
efficiency in a human lymphocyte cellular model were assessed with the aim to select the most suitable approach 
to obtain CNPs for biomedical applications.
Results and Discussion
CNP synthesis and physico-chemical properties. Five different CNP samples were synthesized using 
two different precipitation methods, as summarized in Table 1.
TEMED-induced precipitation in the presence of Pluronic F127. As a first attempt, the N,N,N0,
N0-tetramethylethylenediamine (TEMED)-induced precipitation reported by Esposito and Traversa7 was slightly 
modified. This synthetic strategy is based on the use of a biocompatible polymer, Pluronic F127, as a synthesis 
co-factor to produce high quality crystalline CNPs7. The nanoparticles obtained have been previously tested in 
several cellular models, showing a good antioxidant activity36, 45, 46, 50. However, in these works the CNPs, which 
were already crystalline after precipitation, were subjected to a post-synthesis thermal treatment to completely 
eliminate the organic residual layer on the nanoparticle surface, inducing a strong tendency to form agglomerates 
that limit their use in vivo36. Therefore, here the post-synthesis thermal treatment of the CNPs was substituted by 
a new washing procedure to selectively eliminate the toxic precipitating agent (TEMED), maintaining the poly-
meric superficial coating (method 1).
Figure 1a shows the XRD pattern and Miller indexes for the as-dried powders obtained with this method 
(named C1, see Table 1), having the crystalline features of the fluorite structure. Scherrer analysis on the (111) 
peak showed an average crystallite size of 8 nm. TEM observations revealed that the powder consisted in nano-
metric semispherical and hexagonal particles with grain size in the 4–10 nm range (Fig. 1b). TGA measurements 
(Fig. 1c) showed a first weight loss of about 1.5 wt% below 200 °C, which was associated with the volatilization 
of the residual solvent and adsorbed water. Then the sample presented a weight loss of about 4 wt% between 200 
and 700 °C, which was attributed to the decomposition of the organic coating on the CNP surface. The nature of 
this coating was studied by FTIR (Fig. 1d) and 1H-NMR (Supplementary Fig. S1) measurements. No traces of 
free TEMED were detected by the 1H-NMR analysis, indicating that the toxic amine compound was successfully 
removed by the washing procedure.
FTIR and 1H-NMR analysis showed the presence of Pluronic F127. FTIR spectra showed different peaks 
between 2970 and 2870 cm−1 belonging to methyl, methylene and methine stretching. The 1H-NMR showed three 
peaks typical of Pluronic F127 at 1.15, 3.56, and 3.75 ppm, which are associated with the hydrogen ions of the free 
methyl of the CHO-CH3 group, of the methine of the CH-O-H group, and of the methylene in the CH2-CH2-O 
and O-CH2-CH2-O groups, respectively51. The signals associated to Pluronic F127 shown in the IR spectrum were 
not very pronounced, in agreement with the low mass loss detected by TGA measurements, possibly indicating 
Sample Synthetic method Surface functionalities
C1 1 Pluronic F127
C1–450 °C 1 None (annealed at 450 °C)
C2 2 Ethylene glycol
C3 2 MEEETES
C4 2 APTES
Table 1. CNP samples prepared with method 1: TEMED induced precipitation in the presence of 
Pluronic F127; and method 2: NH3 induced precipitation in the presence of EG. TEMED: N,N,N0,N0-
tetramethylethylenediamine; EG: ethylene glycol; APTES: (3-aminopropyl)triethoxysilane; MEEETES: 
6-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy}-hexyl)triethoxysilane.
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a limited coordination of the polymer on the CNP surface. The small amount of absorbed Pluronic F127 is not 
sufficient to significantly improve CNP water dispersibility.
Thermally treated CNPs, named C1–450 (see Table 1), were produced for sake of comparison with the previ-
ous work of our group36, 45. Supplementary Figure S2 shows the physico-chemical characterization of the C1–450 
samples. As expected, the thermal treatment at 450 °C completely removed the organic layer without increment-
ing the average grain size7.
Ethylene glycol-assisted precipitation. Another synthesis approach was adopted (method 2 in Table 1) to avoid 
the occurrence of a polymeric layer on the CNP surface and to improve CNP water dispersibility. We took advan-
tage of the ethylene glycol (EG) ability to complex Ce3+ ions to control the reaction homogeneity, setting up a 
simple ammonia induced direct precipitation process. Similar low temperature direct precipitation synthesis of 
CNPs in EG/water mixed solvents was previously described by other groups34, 52. Herein the reaction conditions 
reported in ref. 52 were optimized by modifying the ethylene glycol concentration and by choosing the pH to 
maximize EG coordination to Ce3+. EG to Ce3+ molar ratio was chosen to be 10 to 1, slightly larger than the theo-
retical Ce3+ coordination ratio in the presence of nitrate ions53. The coordination dependence upon the variation 
of the pH was studied by 1H-NMR titration (Supplementary Fig. S3), analyzing the EG peak broadening at 3.66 
ppm. Paramagnetic lanthanide ions such as Ce3+ are known in NMR measurements for their ability to induce 
paramagnetic relaxation enhancement (PRE), an effect that causes the signals of the resonant spins surrounding 
the metal ion to broaden once they are coordinated to the metal54. On this basis, to study the Ce3+-ethylene glycol 
binding, the pH was varied between 3 and 11. As shown in Supplementary Fig. S3, a maximum in EG peak broad-
ening was reached between 9.2 and 9.7; hence the reaction pH was fixed at 9.6.
Figure 2 shows the physico-chemical characterization of the obtained CNPs (C2, see Table 1). As shown in 
Fig. 2a, C2 particles were already crystalline after drying and showed a fluorite structure, with an average dimen-
sion (calculated by Scherrer analysis) of 11 nm. TEM analysis (Fig. 2b) showed mono-crystalline semispherical 
and hexagonal particles, with grain size ranging 7–15 nm. TGA analysis (Fig. 2c) showed two main regions of 
weight loss. The first loss of about 0.5 wt%, which occurred below 200 °C, was associated with the volatilization 
Figure 1. Physico-chemical characterization of C1 nanoparticles. (a) XRD diffraction patterns and Miller 
indexes of C1. (b) TEM image. (c) TGA curve. (d) FTIR absorbance spectra with the inset of the CH2 stretching 
zone.
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of the residual ethanol and water solvents, while the 2.7 wt% loss between 200 and 800 °C was associated with the 
decomposition of the ethylene glycol residual layer on the dried powder surface. The presence of a superficial EG 
coating was confirmed by the FTIR analysis (Fig. 2d), which showed three peaks between 2970 and 2840 cm−1 
typical of the methylene stretching of ethylene glycol molecules55.
CNP silanization. In order to obtain water dispersible CNPs, a post-synthesis functionalization strategy of 
C2 nanoparticles with small hydrophilic molecules was developed. Silanization of the CNPs was then performed 
taking advantage of the high reactivity of the silanes towards the hydroxyl groups present on the surface. The 
above-mentioned approach was largely employed by many groups to introduce PEG and amine functionalities 
onto magnetic oxide nanoparticles56–58, as well as for silica nanoparticles59–61, but was scarcely investigated for 
CNPs62. Two small hydrophilic biocompatible silane molecules, 6-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy}-
hexyl)triethoxysilane (MEEETES) and 3-Aminopropyltriethoxysilane (APTES), were chosen for this purpose. 
APTES organo-silane was selected for the presence of the hydrophilic amino terminal group that can be used as 
a linker to allow further surface functionalization with a variety of bio-molecules. On the other hand MEEETES 
showed the best hydrophilic properties among all the organo-silane of our interest63.
Figure 3 shows the characterization of the samples after silanization. Figure 3a shows the TGA curves of the 
C3 (MEEETES) and C4 (APTES) samples compared with the C2 sample. Samples C3 and C4 showed a weight loss 
increment of 4.3% and 0.6% (vs C2 sample) between 200 and 700 °C, associated with the thermal decomposition 
of the silanes. These values are compatible with the formation of a silane monolayer on the CNP surface. FTIR 
(Fig. 3b) and 1H-NMR (Fig. 3c) analyses confirmed the presence of APTES and MEEETES ligand shell. The peaks 
between 2950 and 2850 cm−1 are due to CH2 stretching in the silane carbon chains. The introduction of silane lig-
ands onto the CNP surface was demonstrated by the absorption bands in the 1130–1000 cm−1 and 950–810 cm−1 
ranges, signals that are typical of siloxane and silanol groups, respectively21, 22. Importantly, the peak at 852 cm−1 
due to the Ce-O-Si silanolate band indicated the formation of a covalent ligand binding between the silane ligands 
and the hydroxyl groups on the CNP surface23, 64. The presence of the NH bending band at 1554 cm−1, which can 
be ascribed to the amide bond, confirmed the effective functionalization of CNPs with APTES24. The 1H-NMR 
spectra (Fig. 3c) presented several broad peaks that can be assigned to the ligand molecules bound on the surface. 
Nine characteristic peaks for MEEETES and four for APTES were observed, which were attributed to the APTES 
and MEEETES chains, as shown in Fig. 3c, confirming the success of the functionalization strategy.
Figure 2. Physico-chemical characterization of C2 nanoparticles. (a) XRD diffraction patterns and Miller indexes. 
(b) TEM image. (c) TGA curve. (d) FTIR absorbance spectra; the inset shows the CH2 stretching zone.
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CNP dispersion properties. CNP tendency to agglomerate in water and in physiological media was 
measured by DLS analysis. Table 2 summarizes the average hydrodynamic diameter of all the samples, while 
Supplementary Figure S4 shows the CNP size distribution profile reported by volume. With respect to C1, larger 
values of hydrodynamic diameter were observed for C1–450 in water, but only slightly larger in cell media. In 
addition, the C1 hydrodynamic diameter distribution presents two distinct populations of agglomerates, one at 
about 100 nm and the other at 250 nm (Fig. S4), being a highly polydispersed sample. It might be inferred that 
the presence of the Pluronic superficial coating only slightly reduced the nanoparticle tendency to agglomerate.
Figure 3. C2 nanoparticle surface silanization. (a) TGA analysis of C2, C3 and C4 samples. (b) FTIR 
absorbance spectra. (c) 1H-NMR spectra of C3 and C4 samples. The peaks were assigned to the APTES and 
MEEETES molecular structures.
NPs
H2O RPMI + 10% FBS
d (nm) Z pot. (mV) d (nm) Z pot. (mV)
C1 164 ± 8 −23 ± 1 232 ± 9 −2 ± 1
C1–450 244 ± 5 −36 ± 1 276 ± 12 −7 ± 1
C2 222 ± 42 −27 ± 1 206 ± 7 −10 ± 1
C3 110 ± 8 −25 ± 1 110 ± 5 −10 ± 1
C4 1230 ± 60 14 ± 1 357 ± 23 −12 ± 1
Table 2. Summary of DLS and zeta potential results for the tested CNPs. d: average hydrodynamic 
diameter ± standard deviation over three measurements obtained by cumulant analysis. Z_pot: zeta potential 
average ± standard deviation over three measurements.
www.nature.com/scientificreports/
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The dispersion stability of C1 nanoparticles in water (pH 7.4) was studied over time, following their precipita-
tion for 14 days. C1 dispersion was let to sediment at ambient conditions; the CNP concentration into the super-
natant was evaluated by measuring UV-Vis spectra, following the decrease of cerium absorbance peak around 
300 nm25, 34, 41, as shown in Supplementary Fig. S5. C1–450 nanoparticles were excluded from the analysis since 
they completely precipitated within hours. Figure 4 shows that after 14 days only 10 wt% of the C1 nanoparticles 
was kept in the supernatant.
Therefore, by modifying the synthesis method reported by Esposito and Traversa7, the CNP dispersibility 
was partially improved, but the agglomeration issue was not satisfactorily solved. To obtain better results, the 
new synthetic and functionalization strategies were designed. DLS analysis of the CNPs obtained by EG assisted 
synthesis (C2) showed a lower tendency to agglomerate (vs C1). Their stability in water was studied over time, as 
described for the C1 sample (Fig. 4). C2 nanoparticles were much more stable in water, since more than 62 wt% of 
the original concentration remained stable into the supernatant for two weeks. However, the DLS hydrodynamic 
profile of C2 was characterized by a significant polydispersity (Supplementary Fig. S4).
As a next step, we explored the behavior of C2 after surface functionalization with APTES and MEEETES 
and we analyzed agglomeration and stability in water based media. CNPs functionalized with APTES (C4) pre-
sented a strong tendency to agglomerate. The hydrodynamic diameter distribution in water (Supplementary 
Fig. S4) showed a mono-dispersed population around 1 μm. Moreover, these NPs were completely precipitated 
within hours if left to sediment at room temperature. The low stability of the C4 formulation may be explained 
by crosslinking among CNPs during functionalization induced by the presence of the amine functionality in the 
APTES molecule, which facilitates the formation of siloxane bonds (detected by FT-IR, see Fig. 3b). Hence, our 
evidence clearly showed that CNP functionalization with APTES is not suitable for biomedical applications.
CNP functionalized with MEEETES (C3) were much less agglomerated than C2, presenting a population with 
an average hydrodynamic diameter peaked at 45 nm. Interestingly, C3 was the only sample that did not need a 
sonication procedure to be properly dispersed. Importantly, almost 80 wt% of the C3 nanoparticles remained into 
the supernatant after two weeks (Fig. 4), showing a very good stability in water-based media.
The surface charge of CNP samples was measured by zeta potential analysis, both in water (pH 7.4) and 
in cellular culture media. The average values are reported in Table 2. In water, CNP surface charge was clearly 
influenced by the surface coating, being negative in the case of Pluronic 127 (C1), MEEETES (C3), and in the 
presence of hydroxyl surface groups (C2 ad C1–450 °C), while it became positive in the presence of APTES, 
reflecting the presence of partially protonated APTES amino groups (C4). When CNP samples came in contact 
with serum proteins, the nanoparticles superficial charge was reduced to slightly negative values independently of 
the coating, meaning that the formation of a protein layer on the CNPs surface (protein corona) in physiological 
media completely shielded their original surface charge. The reduction of NP surface charge values induced more 
agglomeration phenomena in all the CNPs tested, except for the C3 sample: in this case, the mean hydrodynamic 
diameter of the main population was reduced from 45 to 30 nm.
Radical scavenging by CNPs in abiotic systems. The ability of CNPs to scavenge hydroxyl radical 
(HO●) was studied by electron spin resonance (ESR) measurements. Hydroxyl radicals were generated irradiating 
TiO2 nanoparticle dispersions with ultraviolet radiation, taking advantage of the well known TiO2 photocatalytic 
activity65, 66. Since the lifetime of HO● at room temperature is very low (100 μs), the HO● formation and decay 
in the presence of CNPs was studied using DMPO spin trap. The ESR spin trap technique takes advantage of spin 
trap molecule ability to react with free radicals, forming a more stable spin adduct with paramagnetic parameters 
that depend on the nature of the trapped radical67. In this work, the CNP redox activity was estimated by quanti-
fying the formation of DMPO adducts in the absence (Fig. 5a, TiO2 spectrum) or in the presence of CNPs (Fig. 5a, 
TiO2 + CNPs spectra). In the absence of CNPs, the typical DMPO-OH spectrum was detected, consisting of four 
lines with peak intensity ratios of 1:2:2:1 and hyperfine coupling constants AN and AH for 14N and 1H equal to 
14.9 G (Fig. 5a)67, 68. All the CNPs significantly reduced the DMPO-OH signal, showing a strong HO● scavenging 
activity. The reduction of DMPO-HO signal was quantified by integrating the ESR spectra and reported in the 
table in Fig. 5a.
Figure 4. CNP colloidal stability over time. C1, C2, and C3 sample residual concentration into the supernatant 
after 7 and 14 days.
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C1–450 and C2 reduced the DMPO-OH signal by 85–90%. C1 and C3 completely abolished the DMPO-OH 
signal. C4 scavenged HO● much less than the other CNP samples, in agreement with their tendency to agglom-
erate; the reduced CNP active area impaired their redox activity. Interestingly, C2 spectra showed some traces of 
DMPO-OOH abduct characterized by a AN 14.12 G, and AH of 11.3 G hyperfine coupling constants27, 67, super-
imposed to the DMPO-OH residual spectra (Fig. 5a). Since no traces of superoxide forming DMPO-OOH were 
detected in the control spectra, this evidence indicates that C2 samples possess an additional activity, producing 
some extent of superoxide radicals while reacting with HO●.
The decomposition of 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPOL) free radical into 
2,2,6,6-tetramethylpiperidinone 1-oxyl (TEMPONE) induced by HO● was measured in the presence or in the 
absence of CNPs, as an alternative method to validate the reactivity of CNPs (Supplementary Fig. S6A). TEMPOL 
decomposition kinetics and the consequent TEMPONE formation were followed for 525 s, under a continuous 
Figure 5. Abiotic analysis of CNP redox activity. (a) ESR spectra of DMPO spin abduct signals produced 
by UV-irradiated TiO2 suspensions at 800 µg/mL ± CNPs at 400 µg/mL. On the right a table reporting the 
DMPO-OH residual signal in the presence of C1, C1–450, C2, C3, and C4 samples. (b) ESR analysis of 
TEMPOL decomposition into TEMPONE during continuous irradiation of TiO2 (800 µg/mL) ± CNPs (400 µg/
mL). On the left the TEMPOL signal reduction and the TEMPONE formation kinetics for 525 s, on the right % 
of TEMPOL disappearance and TEMPONE formation after 525 s.
www.nature.com/scientificreports/
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generation of HO●. Figure 5b shows the increment of the TEMPONE signal over time; Supplementary Figure S6 
shows the ESR spectra measured after 525 s. In agreement with the DMPO data, C1 and C3 nanoparticles were 
very active in scavenging HO●, reducing TEMPOL decomposition, and thereby TEMPONE formation by 70% 
and 62%, respectively. On the other hand, C2 and C1–450 only partially reduced the TEMPONE formation (35% 
and 25% reduction), being much less active.
Our findings indicate that CNP redox activity in abiotic systems is only partially correlated with their dispers-
ibility. For example, C3 and C1 showed similar reactivity in scavenging HO● free radicals but different dispersion 
properties (Supplementary Fig. S4). Moreover, C2 samples showed an interesting additional activity producing 
a small amount of superoxide. Therefore, we hypothesized that the CNP surface coating could play an important 
function in determining the CNP redox properties.
CNP biocompatibility. It is well known that the CNP physico-chemical properties, including size25, 28, 36, 
shape35, 69, surface area25, 30, surface charge31, 70, and the presence of surface contaminants32, 41, 44, affect the CNP 
biocompatibility. Therefore, CNP effects on cell viability were tested in Jurkat human T lymphocytes, a mam-
mal cell model previously systematically investigated in terms of cellular response to various exogenous stress 
sources33, 36, 71. Cells were treated with CNPs at a final concentration up to 200 μg/mL. Cellular proliferation and 
induction of apoptosis or necrosis were monitored during a period of 24–72 h, showing that none of the pow-
ders tested caused cytotoxic effects. CNPs did not impair cellular proliferation, as shown by cell counts (Fig. 6a), 
neither they induced a significant increment of basal apoptosis or necrosis. Moreover, CNPs reduced basal ROS 
levels (significantly for C2, C3 and C4), as shown in Fig. 6b.
CNP biological activity on Jurkat cells. CNPs are known to protect cells from oxidative stress sources 
(e.g. H2O2, UV rays, ionizing radiation) buffering ROS and therefore reducing oxidative stress damage to cellular 
bio-macromolecular structures12, 29, 50, 69, 72. This protective action against a superimposed oxidative stress con-
dition was tested with the aim to compare the biological activity of the different CNP samples. To this purpose, 
Jurkat cells were pre-incubated with CNP suspensions at 100 μg/mL, and then treated with a strong oxidant agent, 
hydrogen peroxide (H2O2).
Figure 7 shows the CNP protection against H2O2 and UVB induced ROS production and apoptosis. All the CNPs 
tested, except for C4, significantly reduced the extent of hydrogen peroxide noxious action, buffering the increase 
in ROS levels (Fig. 7a) and protecting cells from apoptosis (Fig. 7b). C3 sample was significantly more effective than 
the other samples, as confirmed by ANOVA mean comparison analysis between the different treatments (#p < 0.05). 
Figure 7c shows that the functionalized particles maintain a strong protecting activity against UVB-induced apop-
tosis50; in particular, C3 exerts an anti-apoptotic effect significantly stronger that the pristine particles.
To further compare the extent of antioxidant activity of the different CNP samples and their ability to inhibit 
the redox-dependent apoptotic process, we followed the approach reported by Celardo et al.36. Apoptosis 
was induced by treating cells with VP16, a topoisomerase II inhibitor. As reported in Supplementary Fig. S7, 
pre-treatment with the C1, C2 and C3 samples at a final concentration of 100 μg/mL significantly reduced VP16 
induced apoptosis. Only the C4 sample was completely ineffective. Confirming the results obtained with H2O2 
treatment, C3 showed a significantly higher inhibition of apoptosis than the other powders, suggesting that the 
biological activity of the different CNPs powders strongly correlate with the CNP water dispersibility.
Finally, we investigated whether the CNP supernatants maintained their biological activity over time. 
Therefore, CNP stock solutions were let to sediment at ambient conditions for 7 and 14 days and their activity 
tested as the protection from H2O2-induced apoptosis; cells were pre-incubated with the supernatant for 1 h 
(same volume of stock solution as in the previous experiments) and treated with H2O2. CNP supernatant ability to 
protect from H2O2-induced apoptosis is reported in Fig. 8. The supernatant recovered from C3 (which contained 
Figure 6. CNP nanoparticles do not show any toxicity. (a) Time course of cellular proliferation for 12–72 h 
measured by cells counting reported as number of cells. (b) Basal ROS levels measured by DHR fluorescent 
signal detected by flow cytometry 24 h after cell treatment with CNPs (200 μg/mL). Values are the mean of ≥3 
independent experiments ± SD; *p < 0.05 (ANOVA). Significance with respect to the control group is shown.
www.nature.com/scientificreports/
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about 74 wt% of the pristine NPs) maintained its full activity for two weeks. On the other hand, C1 and C2 super-
natant activity progressively reduced, even though not completely abolished, after 14 days.
In summary, different approaches to synthesize new biocompatible CNPs for medical applications were 
investigated. The previously reported TEMED induced precipitation method in the presence of Pluronic F127 
was improved with the result of reducing CNP agglomeration tendency and enhancing their biological activ-
ity. An ethylene glycol assisted precipitation method followed by an in situ silanization with a poly(ethylene 
glycol)-terminated silane (MEEETES) was developed, significantly improving the CNP water-dispersibility. The 
nanoparticles obtained were highly stable in water for weeks. Moreover, their surface coating did not induce 
any toxicity neither influenced their redox activity. Importantly, all the particles maintained satisfactory redox 
activity: in particular, MEEETES functionalized nanoparticles showed a significantly higher biological activ-
ity (vs non-functionalized particles) that strongly correlates with their higher stability in physiological media, 
pointing to its use in further biological antioxidant applications. In conclusion, we showed that the water/eth-
ylene glycol-based precipitation synthesis followed by in situ surface functionalization with a poly(ethylene gly-
col)-terminated silane is a promising method to obtain CNPs potentially highly active in biomedical applications.
Methods
Materials. All the reagents and solvents were purchased from Sigma-Aldrich, with the exception of 
6-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy}-hexyl)triethoxysilane (Sikemia) and Dihydrorhodamine 
(Molecular Probes). Stock solutions of Hoechst 33342 (10 mg/mL), and PI (5 mg/mL) were dissolved in distilled 
water; DHR (10 mM) was dissolved in dimethyl sulfoxide.
CNP synthesis. Method 1. Pluronic F-127 (6.5 g, 0.08 mol) was dissolved in 300 mL of Milli-Q water. 
After 1 h, Ce(NO3)3 × 6H2O (15.49 g, 0.036 mol) was poured into the solution, followed by the addition of N,N
,N0,N0-tetramethylethylenediamine (TEMED 17 mL, 0.113 mol). The solution was kept overnight under mild 
Figure 7. Redox active CNPs protect cells from hydrogen peroxide and UVB. (a) ROS levels increment 
measured by DHR fluorescent signal detected by flow cytometry 1 h after cell treatment with H2O2 ± CNPs. (b) 
% of apoptosis detected 24 h after cell treatment with H2O2 ± CNPs. (c) % of apoptosis detected 24 h after cell 
treatment with UVB ± CNPs. Values are the mean of ≥3 independent experiments ± SD; *p < 0.05 (ANOVA). 
Significance with respect to the control group is shown. In (b) and (c) also the significance with respect to the 
C3 group is shown, #p < 0.05 (ANOVA).
Figure 8. CNP redox activity over time. % protection from apoptosis in cells treated with H2O2 ± C1, C2, and 
C3 supernatant suspensions after 7 and 14 days. Values are the mean of ≥3 independent experiments ± SD.
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stirring. NPs were washed by centrifugation in H2O and then dried overnight at 80 °C. The obtained material was 
ground in an agate mortar. To obtain C1–450 °C samples, the powders were annealed at 450 °C for 8 h.
Method 2. Ethylene glycol 95% (7.8 mL, 0.12 mol) was dissolved in 92 mL of Milli-Q water. Then 
Ce(NO3)3 × 6H2O (5.16 g, 0.012 mol) was poured into the solution, followed by the addition of NH3 (4.5 mL) 
to reach pH 9.6. The solution was kept at 50 °C under mild stirring until it became yellow. 50 mL out of 100 mL 
were then collected. The NPs (C2) were washed by centrifugation in EtOH and HμO and dried overnight under 
vacuum at room temperature. 6-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy}-hexyl)triethoxysilane (MEEETES) 
(20 mM) was added to the residual solution (50 mL) and was kept overnight at 50 °C. The functionalized NPs 
(C3) were then washed by centrifugation in EtOH and H2O and dried overnight under vacuum at room temper-
ature. 3-Aminopropyltriethoxysilane (APTES) functionalization (C4 sample) was obtained by a post synthesis 
functionalization of the dried C2 nanoparticles. The NPs (0.5 g) were dispersed in 50 mL of Milli-Q water. Then 
APTES (200 μL, 20 mM) was poured into the dispersion. The pH was adjusted to 9.6, then the reaction was kept 
overnight at 50 °C. The NPs were washed by centrifugation in EtOH and H2O and dried overnight under vacuum.
Ce3+ coordination study. pH dependence of Ce3+ ions coordination by EG was studied by 1H-NMR titra-
tion performed in a Bruker 400 MHz. A solution of 1 mM Ce3+ and 1 mM EG (molar ratio 1:1) was prepared in 
D2O. NMR spectra were measured at different pH from 3 to 12, progressively adding NaOH.
CNP crystal phase, size and morphology. Nanoparticle crystal phase was investigated by X-ray pow-
der diffraction (XRD) analysis using a Philips X’Pert X-ray diffractometer. Crystal structure was identified by 
comparison of d-spacing values with the references taken from the JCPDS database (75–0390 for ceria fluo-
rite structure). The crystallite size of samples, dXRD was estimated from XRD patterns by applying full-width 
half-maximum (FWHM) of (111) characteristic peak to Scherrer equation:
λ θ= . ∗dXRD 0 9 /FWHM cos (1)
where λ is the X-ray wavelength (1.5406 Å in this study) and θ is the diffraction angle for the (111) plane. 
Nanoparticle size and morphology were determined by transmission electron microscopy (TEM) observations, 
using a Philips/FEI CM12 operating at 100 kV.
Nanoparticle ligand shell characterization. The amount of the CNP ligand shell was quantified by ther-
mogravimetric analysis (TGA), using a Perkin Elmer TGA 4000, performed under nitrogen flow (20 mL/min) 
from 30 to 800 °C, with a 5 °C/min heating rate. The chemical composition of NP ligand shell was determined by 
1H-NMR experiments, using a Bruker 400 MHz, and by Fourier-transform infrared spectroscopy (FTIR), using a 
Thermo Scientific Nicolet 6700 equipped with Smart iTR ATR.
Dynamic light scattering and zeta potential measurements. A stock dispersion of CNPs was pre-
pared in deionized water at the concentration of 20 mg/mL. Before performing the experiments, C1, C1–450, 
C2 and C4 samples were dispersed with ultrasounds (Branson Ultrasonic Corp., Danbury, CT, USA) at 20% 
amplitude for 3 minutes, and immediately diluted to the final concentration. C3 stock solution was only shaken 
for 30 seconds with a vortex and then diluted to the final concentration. As described also in ref. 50, zeta potential 
and dynamic light scattering (DLS) measurements of the NPs at the concentration of 200 μg/mL were performed 
at 37 °C in deionized H2O (pH 7.4) and in RPMI medium +10% fetal calf serum using a Malvern Zetasizer, 
Nano-ZS. DLS experiments consisted of 15 runs per measurement and all experiments were repeated three times. 
The mean ± standard deviation (SD) of the hydrodynamic diameter and the polydispersity index (P.I.) were cal-
culated by cumulant analysis. Zeta potential experiments consisted of 100 runs per measurement and all exper-
iments were performed three times. The mean of each triplicate measurement ± standard deviation (SD) was 
taken. Measurements in H2O were made in general purpose mode; measurements in cells media were collected 
in monomodal mode due to the high conductivity of this sample (16 mS/cm). The Smoluchowski approximation 
was used to convert the electrophoretic mobility to zeta potential. To check NP stability in water (pH 7.4) over 
time, CNP stock dispersions were let sediment at ambient condition for 2 weeks. Then, residual concentration 
into the supernatant was determined by measuring CNP suspensions UV-Vis absorption in the range of 200–
800 nm using a UV-Vis spectrometer (Varian Cary 50).
Electron spin resonance (ESR) spectroscopy measurements. CNP ability to scavenge hydroxyl 
radical was assessed by ESR. The ESR measurements were carried out at room temperature using a Bruker 
X-band ESR spectrometer, Bruker Spectrospin Model EleXsys 500, which was equipped with a super-high-Q 
cavity, Bruker Model ER 4122SHQE. HO● radicals were generated by exposing aqueous suspensions 
of TiO2 (anatase) NPs, prepared as in ref. 73, to UV-A light (λex = 365 nm), using a UV spot light source, 
Lightingcure™, model LC-8 (Hamamatsu Photonics, France). During exposure to light, the 2-mL volumes 
of suspensions were equilibrated with oxygen at the atmospheric pressure and stirred vigorously to prevent 
agglomeration of nanoparticles. To avoid overheating by light, the suspensions were maintained at a stabilized 
temperature of 25.0 ± 0.1 °C, using a Thermo Fisher Scientific Haake K10 bath vessel with a temperature con-
trol module. Two different experiments were performed to monitor the changes in hydroxyl radical concentra-
tions in the presence of CNPs:
 (i) 5,5-dimethyl-1-pyrroline N-oxide (DMPO) was used as a spin trap of HO● radicals, thus leading to the 
formation of ESR detectable DMPO/OH spin adducts. Prior to ESR measurements, an aqueous dispersion 
of 800 μg/mL TiO2 ± 400 μg/mL CNPs was sonicated as previously described and then mixed with the 
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stock solution of the spin trap to achieve the final DMPO concentration of 50 mM. Thus, the prepared solu-
tions were exposed to UV-A light for determined time intervals, while being continuously stirred using a 
magnetic bar. After each illumination step, the suspensions volumes of ~15 µL were drawn into thin-walled 
borosilicate glass capillaries (0.7 mm ID, 0.87 mm ID, Model CV7087-100, VitroCom Inc., Mountain 
Lakes, NJ, USA), sealed on both ends with a tube sealant, ChaSeal (Chase Scientific Glass Inc., Rockwood, 
TN, USA). Control ESR measurements were always performed for all the nanoparticle suspensions prior 
to exposing them to light. The typical instrumental settings during these measurements were: microwave 
frequency 9.399 GHz, microwave power 0.64 mW, sweep width 120 G, modulation frequency 100 kHz, 
modulation amplitude 0.5 G, receiver gain 60 dB, time constant 41 ms, conversion time 82 ms, and total 
scan time ~168 s. Routinely, to improve the signal-to-noise ratio, two traces were accumulated for each ESR 
spectrum. Control ESR measurements were performed for all the DMPO-nanoparticle suspensions prior 
to exposing them to light.
 (ii) The ESR measurements of the light-induced decomposition of 4-hydroxy-2,2,6,6-tetramethylpiperidine 
1-oxyl (TEMPOL), accompanied by the formation of 2,2,6,6-tetramethylpiperidinone 1-oxyl (TEM-
PONE), were performed by irradiating with UV-A light the aqueous solution of 100 μM TEMPOL contain-
ing also the dispersed nanoparticles of TiO2 and CeO2 (800 μg/mL TiO2 ± 400 μg/mL CNPs) for 30–525 s 
by implementing the same experimental conditions as described above. The typical instrumental settings 
while monitoring the light-induced decomposition of TEMPOL were: 9.399 GHz, microwave power 
0.64 mW, sweep width 60 G, modulation frequency 100 kHz, modulation amplitude 0.5 G, receiver gain 
60 dB, time constant 20.5 ms, conversion time 84 ms, and total scan time 84 s. The individual contributions 
of ESR signals of TEMPOL and TEMPONE to the overall ESR signal were quantified by simulating the 
respective ESR spectra with the help of WIN-ESR SimFonia.
Cell cultures. Jurkat cells, human tumor T lymphocytes, were grown at 37 °C in RPMI 1640 medium sup-
plemented with 10% fetal calf serum (FCS), 2 mg/mL L-glutamine, 100 IU/mL penicillin and streptomycin, in a 
humidified atmosphere of 5% CO2 in air. All experiments were performed on cells in the logarithmic phase of 
growth under condition of >96% viability. In each experiment, cells were kept at the concentration of 106 cells/
mL36.
Cell treatment with CNPs. NP suspensions were prepared at a stock concentration of 20 mg/mL, dispersed 
as previously described and immediately incubated with Jurkat cells at the final concentration. To check the 
supernatant residual activity, CNP stock solutions were let to sediment for 1–2 weeks at ambient temperature. 
Then, parallel experiments were performed treating cells with the same volume of supernatant or of a freshly 
prepared stock solution.
Analysis of cell proliferation. The rate of cell proliferation was assessed after incubating cells with CNPs 
up to 200 μg/mL concentration for 24–72 h, by evaluating cell concentration using a Bruker counting chamber; 
values are given as number of 104 cell/mL.
Detection and quantification of intracellular ROS. Reactive oxygen species (ROS) were measured by 
dihydrorhodamine (DHR), a probe that is internalized in cells and fluoresces only when oxidized to rhodamine74, 
allowing quantitative assessment of intracellular ROS. DHR was added directly to the cell samples to a final con-
centration of 2 µM and incubated at 37 °C in the dark for 20 min; then cells were analyzed by FACSCalibur flow 
cytometer; 10,000 cells were analyzed for each sample. Data were analyzed with WinMdi 2.9 software; the mean 
values were used for tables and graphs50.
Induction and evaluation of apoptosis. Apoptosis was induced by the following agents:
 (i) 200 μM hydrogen peroxide, added to medium culture;
 (ii) 100 μM etoposide, a topoisomerase II inhibitor inducing apoptosis via DNA damage.
 (iii) UVB (312 nm, Spectroline lamp model ENB-260C/FE) single exposure at 3 mW/cm2 for 1:30 minute.
Cells were pre-treated with 100 μg/mL CNPs 60 min prior to the experiment.
Apoptosis was evaluated quantifying the fraction of apoptotic nuclei by fluorescence microscopy after DNA 
staining with the cell-permeable specific dye Hoechst 33342, directly added to the cell culture at the final con-
centration of 10 µg/mL36. To evaluate the eventual presence of necrotic cells, cells were also stained with PI at a 
final concentration of 5 µg/mL. The fraction of apoptotic nuclei among the total cell population was calculated 
by counting at the fluorescence microscope at least 300 cells in at least three independent randomly selected 
microscopic fields.
Statistical analysis. Each experiment was repeated ≥3 times. Data are presented as means ± SD. Statistical 
evaluation was conducted by one-way ANOVA analysis, followed by Tukey’s Multiple Comparison Test 
(Homogeneous Variances) using the software Origin 8.0. Statistical significance was set at p < 0.05.
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